Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

NCT05368623 · clinicaltrials.gov ↗

COMPLETED

Status

1100

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetic Retinopathy
Diabetic Macular Edema
Diabetic Eye Problems

Interventions

DIAGNOSTIC_TEST: Color fundus photograph
DIAGNOSTIC_TEST: Optical Coherence Tomography (OCT) of the retina
DRUG: Mydriatic Agent

Sponsor

RETINA-AI Health, Inc.